YW, C., YW, K., SW, C., YH, C., & TF, C. (2026). Effect of SGLT2 inhibitors versus DPP4 inhibitors on major adverse kidney events in diabetic people with varied kidney function decline. Frontiers in endocrinology, 16, 1647342. https://doi.org/10.3389/fendo.2025.1647342
Chicago Style (17th ed.) CitationYW, Cheng, Kao YW, Chen SW, Chan YH, and Chao TF. "Effect of SGLT2 Inhibitors Versus DPP4 Inhibitors on Major Adverse Kidney Events in Diabetic People with Varied Kidney Function Decline." Frontiers in Endocrinology 16 (2026): 1647342. https://doi.org/10.3389/fendo.2025.1647342.
MLA (9th ed.) CitationYW, Cheng, et al. "Effect of SGLT2 Inhibitors Versus DPP4 Inhibitors on Major Adverse Kidney Events in Diabetic People with Varied Kidney Function Decline." Frontiers in Endocrinology, vol. 16, 2026, p. 1647342, https://doi.org/10.3389/fendo.2025.1647342.